Yahoo Web Search

Search results

    • Gateway - Quartz

      Quartz· 6 hours ago

      23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock is so close ...

    • Some CRISPR screens may be missing cancer drug targets

      Science Daily· 4 days ago

      This means that Cas9 won't make a cut and disable a specific gene, thereby obscuring a potential role of that gene in cancer growth. The team found that this happens disproportionately in cells ...